查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1705544

2025年骨科生物製品全球市場報告

Orthobiologics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年骨科​​生物學市場規模將強勁成長。到 2029 年，這一數字將成長至 97 億美元，複合年成長率為 6.5%。預測期內的成長可歸因於人口老化和久坐的生活方式、先進產品的持續開發、有利的報銷政策、新生物正畸產品的監管核准以及現有生物正畸產品適應症的擴大。預測期內的關鍵趨勢包括再生醫學的進步、產品創新、技術進步、策略性舉措和市場擴張。

預計未來交通事故和運動傷害發生率的上升將推動骨科生物製劑市場的成長。交通事故和運動傷害通常會對肌肉骨骼系統造成人身傷害。這些事故受到分心駕駛、超速、道路狀況不佳、過度使用、設備不當以及缺乏運動相關傷害訓練等因素的影響。骨生物學在治療這些損傷中發揮關鍵作用，它透過促進肌肉骨骼組織更快、更有效地癒合，減少炎症，並使用骨移植、生長因子、幹細胞和富含血小板的血漿等物質增強身體的自然修復過程。例如，2024年3月，歐盟統計局（Eurostat）報告稱，2022年歐洲道路交通事故死亡人數達到20,653人，而2021年為19,917人，增加了3.7%。因此，預計交通事故和運動傷害的增加將推動骨科生物學市場的發展。

整形外科市場的關鍵參與者正在積極開發先進的解決方案，以改善骨科手術中的骨癒合和融合。例如，乾燥同種異體移植混合物將堅固的皮質纖維與礦化皮質骨結合在一起，以提供結構支撐並促進新骨形成的骨誘導特性。 Isto Biologics 是一家總部位於美國的生技藥品專業公司，於 2024 年 5 月推出了 Fibrant Liberty 移植物。該移植物是堅韌的皮質纖維和礦化皮質取消質碎片的整合組合。這種移植物在水合時會變得有彈性，適合各種外科手術。更長、更強的纖維可改善處理效果並形成網路，防止移植物遷移，同時保持結構完整性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球骨科生物學 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球骨科生物學市場：成長率分析
  • 全球骨科生物製劑市場表現：規模與成長，2019-2024
  • 全球骨科生物製劑市場預測：2024-2029 年及 2034 年規模與成長
  • 全球骨科生物學總目標市場（TAM）

第6章市場區隔

  • 全球骨科生物製劑市場（依產品類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 黏稠補充劑
  • 骨生長因子
  • 去髓鞘化骨基材
  • 合成骨替代品
  • 細胞同種異體移植
  • 其他產品
  • 全球骨科生物製劑市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 脊椎融合手術
  • 顎顏面和牙科
  • 軟組織修復
  • 重組和骨折手術
  • 其他用途
  • 全球骨科生物製劑市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 整形外科診所
  • 門診手術中心
  • 其他最終用戶
  • 全球骨科生物製劑市場黏性補充劑細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 玻尿酸注射
  • 凝膠型黏稠補充劑
  • 交聯玻尿酸
  • 其他濃稠補充劑產品
  • 全球骨科生物製劑市場骨生長因子細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 骨形成蛋白（BMP）
  • 重組人類骨形成蛋白（rhBMP）
  • 富血小板血漿（PRP）
  • 骨形成蛋白-1（OP-1）
  • 促進骨癒合的生長因子
  • 全球骨科生物製品市場去礦物質骨基質細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • DBM 移植
  • DBM膩子
  • DBM海綿
  • DBM 糊劑和碎片
  • 全球骨科生物製品市場，人造骨細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 磷酸鈣替代品
  • 硫酸鈣基替代品
  • 磷酸三鈣（TCP）
  • 羥磷石灰（HA）
  • 生物活性玻璃
  • 其他合成骨替代品
  • 全球骨科生物製劑市場細胞同種異體移植細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 骨細胞同種異體移植
  • 間質幹細胞（MSC）異基因移植
  • 異基因骨髓來源細胞移植
  • 脂肪組織來源的細胞同種異體移植
  • 全球骨科生物製劑市場、其他產品細分、按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 自體移植
  • 膠原蛋白移植物
  • 合成移植骨替代物（非生物活性）
  • 羊膜移植
  • 基於外泌體的產品
  • 其他骨科及生物製品

第7章 區域和國家分析

  • 全球骨科生物製劑市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球骨科生物製劑市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 骨科生物學市場：競爭格局
  • 骨科生物學市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
    • Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • NuVasive Inc.
  • Globus Medical
  • Bioventus
  • MTF Biologics
  • ATEC Spine Inc.
  • Exactech Inc.
  • SeaSpine
  • RTI Surgical
  • AlloSource
  • XTANT MEDICAL
  • Spine Wave Inc.
  • Bone Biologics Corp.
  • Locate Bio Limited
  • Wright Medical Group NV
  • BoneSupport AB

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年骨科生物製品市場：提供新機會的國家
  • 2029 年骨科生物製品市場：細分領域帶來新機會
  • 2029 年骨科生物製品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30858

Orthobiologics refer to therapies derived from natural substances utilized in treating various musculoskeletal conditions. These therapies aim to enhance the body's capacity to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments, ultimately improving recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

The main products of orthobiologics include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone substitutes, cellular allografts, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, thereby reducing pain and enhancing mobility in individuals with osteoarthritis. These products find applications across various fields, including spinal fusion, maxillofacial and dental surgeries, soft tissue repair, reconstructive and fracture surgery, and others. They are utilized by various end users such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides orthobiologics market statistics, including the orthobiologics industry global market size, regional shares, competitors with orthobiologics market share, detailed orthobiologics market segments, market trends, and opportunities, and any further data you may need to thrive in the orthobiologics industry. These orthobiologics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthobiologics market size has grown strongly in recent years. It will grow from $7.08 billion in 2024 to $7.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rise in prevalence of orthopedic diseases and conditions, shift towards minimally invasive procedures, rise in number of reconstructive surgeries, increase in healthcare expenditure, awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

The rising incidence of road accidents and sports injuries is expected to drive the growth of the orthobiologics market in the future. Road accidents and sports injuries involve physical harm to individuals, often affecting the musculoskeletal system. These incidents are influenced by factors such as distracted driving, speeding, poor road conditions, overuse, improper equipment, and insufficient training for sports-related injuries. Orthobiologics play a key role in treating these injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes using substances like bone grafts, growth factors, stem cells, and platelet-rich plasma. For example, in March 2024, Eurostat, the European Union's statistical office, reported that in 2022, 20,653 people were killed in road accidents in Europe, an increase of 3.7% compared to 19,917 fatalities in 2021. As a result, the growing number of road accidents and sports injuries is expected to propel the orthobiologics market.

Key players in the orthobiologics market are actively developing advanced solutions to improve bone healing and fusion in orthopedic procedures. Dry allograft mixtures, for instance, combine sturdy cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties for new bone formation. Isto Biologics, a US-based biologics-focused company, introduced Fibrant Liberty allograft in May 2024, featuring robust cortical fibers integrated with mineralized cortical cancellous chips. This graft, upon hydration, becomes pliable and can be tailored for various surgical procedures. Its longer and stronger fibers improve handling and form a network that prevents graft migration while maintaining structural integrity.

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, completed the acquisition of Embody Inc. for $155 million. This strategic move underscores Zimmer's commitment to investing in areas with significant growth potential and introducing innovations to benefit patients and surgeons. Embody, a US-based soft tissue healing company, specializes in developing and manufacturing collagen-based biologic products for soft tissue augmentation and repair. The acquisition includes Embody's comprehensive portfolio of collagen-based biointegrative solutions aimed at supporting healing in challenging orthopedic soft tissue injuries.

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthobiologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthobiologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthobiologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthobiologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthobiologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
  • 2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
  • 3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products
  • 2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing
  • 3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips
  • 4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes
  • 5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts
  • 6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet; Arthrex Inc.; Integra Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orthobiologics Market Characteristics

3. Orthobiologics Market Trends And Strategies

4. Orthobiologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Orthobiologics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Orthobiologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Orthobiologics Market Growth Rate Analysis
  • 5.4. Global Orthobiologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Orthobiologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Orthobiologics Total Addressable Market (TAM)

6. Orthobiologics Market Segmentation

  • 6.1. Global Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viscosupplements
  • Bone Growth Factors
  • Demeneralized Bone Matrix
  • Synthetic Bone Substitutes
  • Cellular Allograft
  • Other Products
  • 6.2. Global Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Fusion
  • Maxillofacial And Dental
  • Soft Tissue Repair
  • Reconstructive And Fracture Surgery
  • Other Applications
  • 6.3. Global Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.4. Global Orthobiologics Market, Sub-Segmentation Of Viscosupplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid Injections
  • Gel-Based Viscosupplements
  • Cross-linked Hyaluronic Acid
  • Other Viscosupplement Products
  • 6.5. Global Orthobiologics Market, Sub-Segmentation Of Bone Growth Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Morphogenetic Proteins (BMPs)
  • Recombinant Human Bone Morphogenetic Proteins (rhBMPs)
  • Platelet-Rich Plasma (PRP)
  • Osteogenic Protein-1 (OP-1)
  • Growth Factors For Bone Healing
  • 6.6. Global Orthobiologics Market, Sub-Segmentation Of Demineralized Bone Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DBM Grafts
  • DBM Putty
  • DBM Sponges
  • DBM Paste And Chips
  • 6.7. Global Orthobiologics Market, Sub-Segmentation Of Synthetic Bone Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Calcium Phosphate-Based Substitutes
  • Calcium Sulfate-Based Substitutes
  • Tricalcium Phosphate (TCP)
  • Hydroxyapatite (HA)
  • Bioactive Glasses
  • Other Synthetic Bone Substitutes
  • 6.8. Global Orthobiologics Market, Sub-Segmentation Of Cellular Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osteocellular Allografts
  • Mesenchymal Stem Cells (MSCs) Allografts
  • Bone Marrow-Derived Cellular Allografts
  • Adipose Tissue-Derived Cellular Allografts
  • 6.9. Global Orthobiologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autografts
  • Collagen-Based Grafts
  • Synthetic Bone Graft Substitutes (Non-Bioactive)
  • Amniotic Membrane-Based Grafts
  • Exosome-Based Products
  • Other Miscellaneous Orthobiologic Products

7. Orthobiologics Market Regional And Country Analysis

  • 7.1. Global Orthobiologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Orthobiologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orthobiologics Market

  • 8.1. Asia-Pacific Orthobiologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orthobiologics Market

  • 9.1. China Orthobiologics Market Overview
  • 9.2. China Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orthobiologics Market

  • 10.1. India Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orthobiologics Market

  • 11.1. Japan Orthobiologics Market Overview
  • 11.2. Japan Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orthobiologics Market

  • 12.1. Australia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orthobiologics Market

  • 13.1. Indonesia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orthobiologics Market

  • 14.1. South Korea Orthobiologics Market Overview
  • 14.2. South Korea Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orthobiologics Market

  • 15.1. Western Europe Orthobiologics Market Overview
  • 15.2. Western Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orthobiologics Market

  • 16.1. UK Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orthobiologics Market

  • 17.1. Germany Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orthobiologics Market

  • 18.1. France Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orthobiologics Market

  • 19.1. Italy Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orthobiologics Market

  • 20.1. Spain Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orthobiologics Market

  • 21.1. Eastern Europe Orthobiologics Market Overview
  • 21.2. Eastern Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orthobiologics Market

  • 22.1. Russia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orthobiologics Market

  • 23.1. North America Orthobiologics Market Overview
  • 23.2. North America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orthobiologics Market

  • 24.1. USA Orthobiologics Market Overview
  • 24.2. USA Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orthobiologics Market

  • 25.1. Canada Orthobiologics Market Overview
  • 25.2. Canada Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orthobiologics Market

  • 26.1. South America Orthobiologics Market Overview
  • 26.2. South America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orthobiologics Market

  • 27.1. Brazil Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orthobiologics Market

  • 28.1. Middle East Orthobiologics Market Overview
  • 28.2. Middle East Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orthobiologics Market

  • 29.1. Africa Orthobiologics Market Overview
  • 29.2. Africa Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orthobiologics Market Competitive Landscape And Company Profiles

  • 30.1. Orthobiologics Market Competitive Landscape
  • 30.2. Orthobiologics Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Orthobiologics Market Other Major And Innovative Companies

  • 31.1. NuVasive Inc.
  • 31.2. Globus Medical
  • 31.3. Bioventus
  • 31.4. MTF Biologics
  • 31.5. ATEC Spine Inc.
  • 31.6. Exactech Inc.
  • 31.7. SeaSpine
  • 31.8. RTI Surgical
  • 31.9. AlloSource
  • 31.10. XTANT MEDICAL
  • 31.11. Spine Wave Inc.
  • 31.12. Bone Biologics Corp.
  • 31.13. Locate Bio Limited
  • 31.14. Wright Medical Group N.V.
  • 31.15. BoneSupport AB

32. Global Orthobiologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orthobiologics Market

34. Recent Developments In The Orthobiologics Market

35. Orthobiologics Market High Potential Countries, Segments and Strategies

  • 35.1 Orthobiologics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Orthobiologics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Orthobiologics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer